NCT00262015

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

A Phase IV, Single Center, Open-Label, Controlled, Randomized Study to Evaluate the Memory Response of Children Previously Vaccinated With Chiron Meningococcal C Conjugate Vaccine, Menjugate® and Describe the Kinetic of the Antibody Response and Maturation on Days 2-7 and 28 After Challenge With Pasteur Merieux Meningococcal A/C Polysaccharide Vaccine or Menjugate®

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 264 (planned)
• Sponsor: Chiron Corporation · Industry
• Sex: All
• Age: 13 Years – 15 Years
• Healthy volunteers: —

Summary

The purpose of this study is to determine when a memory immune response after re-vaccination with Meningococcal C conjugate vaccine (Menjugate) or challenge with Meningococcal A/C polysaccharide vaccine can be observed, after initial vaccination with Meningococcal C conjugate vaccine during the UK immunization campaign

Conditions

• Meningococcal Disease; Meningococcal Meningitis

Interventions

Type	Name	Description
BIOLOGICAL	· Meningococcal C conjugate vaccine; Meningococcal A/C Polysaccharide vaccine (partial dose)

Timeline

• Start date: 2003-09-01
• First posted: 2005-12-06
• Last updated: 2005-12-06

Locations

1 site across 1 country: United Kingdom